Tianjin Pharmaceutical Da Ren Tang updates on subsidiary’s bankruptcy liquidation
SGX Filings
Jun 30
On Jun, 30 2026, Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited announced that there have been no material developments in the bankruptcy liquidation of its 55%-owned subsidiary, Tianjin Shin Poong Pharmaceutical Co., Ltd., since the previous update on Jun, 2 2026.
The company stated it will keep monitoring the proceedings, maintain communication with the court and the administrator, and continue issuing monthly updates in line with listing requirements. It also advised shareholders and potential investors to exercise caution when dealing in its shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.